Latest news
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTScottish National Investment Bank backs Glasgow firm with £8.4m - The HeraldThe Herald · Thu, 06 Aug 2026 05:06:44 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMTMironid raises USD 46m to advance first-in-class ADPKD therapy - allsci.comallsci.com · Wed, 05 Aug 2026 15:58:20 GMTGlasgow Biotech Mironid Secures £34m Series B Funding - digit.fyidigit.fyi · Wed, 05 Aug 2026 15:34:16 GMTGlasgow biotech raises £34m in Series B funding round - Insider Media LtdInsider Media Ltd · Wed, 05 Aug 2026 07:04:00 GMTMironid - Via RitzauVia Ritzau · Wed, 05 Aug 2026 06:00:00 GMT